Plain-English translation of NCT06984562 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This clinical trial is testing Adaptive Radiation Therapy (ART) as a treatment for locally advanced pancreatic cancer that cannot be surgically removed. ART is a new approach to radiation therapy that adjusts the radiation beam during treatment to better target cancer cells and spare surrounding healthy tissue. The study wants to see if this treatment is safe, effective, and can reduce side effects compared to standard radiation therapy.
Pancreatic cancer that has grown into nearby blood vessels often cannot be removed by surgery, leaving radiation therapy as an important treatment option. This new treatment aims to improve how well radiation targets the most aggressive cancer cells while reducing damage to healthy organs nearby, potentially helping patients live longer with fewer side effects.
You likely qualify if…
You likely don't qualify if…
You will have CT scans to precisely plan your radiation treatment, and small markers may be placed near your tumor to guide therapy. You'll also undergo a biopsy to provide a tissue sample for research. The main treatment involves receiving 5 radiation sessions over a 2-week period (given every other day). Throughout the trial, you'll provide blood samples before, during, and after radiation to help researchers understand how the treatment works and its effects on your body.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
United States